Clinical Trial Update: Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China [Phase 2]

View source ↗

Summary

Phase 2 study of FG-4592 (roxadustat) for anemia in end-stage renal disease patients on maintenance hemodialysis in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia in End Stage Renal Disease | Phase 2 | Status: COMPLETED